The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience

Background. Patients with autoimmune diseases and latent tuberculosis infection (LTBI) are at risk of developing catastrophic tuberculosis disease following infliximab treatment. Quantiferon-TB gold in-Tube (QTB) has proven a more accurate screening tool than tuberculin skin test (TST) in adult popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Maritsi, Despoina, Al-Obadi, Muthana, Brogan, Paul A., Eleftheriou, Despina, Dixon, Garth L. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263741/
https://www.ncbi.nlm.nih.gov/pubmed/22389796
http://dx.doi.org/10.5402/2011/505171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263741/
https://www.ncbi.nlm.nih.gov/pubmed/22389796
http://dx.doi.org/10.5402/2011/505171

Ejemplares similares